PT-141 Peptide

PT-141 (bremelanotide) is an FDA-approved peptide for women designed to support sexual desire by acting on the brain’s arousal pathways. Unlike traditional treatments that focus on circulation or hormone levels alone, PT-141 works centrally to help restore sexual interest and responsiveness.

At SynergenX, PT-141 is offered as part of a personalized, provider-guided treatment plan for women experiencing low libido, reduced arousal, or changes in sexual health.

Starting PT-141 at SynergenX

Getting started is simple. Visit your nearest SynergenX clinic or speak with your provider at your next appointment.

Your care team will evaluate your symptoms, review your labs if needed, and create a personalized plan designed to help you improve sexual desire, confidence, and overall quality of life.

Common Symptoms of Low Sex Drive

Women experiencing low libido may notice:

Persistent low or absent sex drive
Reduced arousal or responsiveness during intimacy
Difficulty maintaining interest or engagement
Decreased sexual satisfaction
Changes in desire related to stress, aging, or hormonal shifts
Loss of confidence connected to intimacy

Key Benefits of PT-141

When prescribed and monitored by a SynergenX provider, PT-141 may help:

Increase sexual desire and interest
Improve arousal and responsiveness
Enhance overall sexual satisfaction
Support confidence and connection in intimate relationships

A Peptide for Sex Drive That Works Differently

PT-141 is a peptide for sex that targets melanocortin receptors in the brain, which play a key role in sexual desire.

Because it works at the neurological level, it offers a different approach than hormone therapy alone, making it a valuable option for women whose symptoms are not fully addressed by HRT.

Can PT-141 Be Combined With Other Therapies?

Yes. PT-141 is often incorporated into a broader treatment plan that may include hormone replacement therapy or other peptides for women.

This approach allows providers to address multiple factors that influence sexual health, including hormone balance, energy, and overall well-being.

Who Is PT-141 For?

PT-141 is FDA-approved for premenopausal women diagnosed with acquired, generalized hypoactive sexual desire disorder (HSDD).

You may be a candidate if you:

Have a low sex drive without a clear underlying medical cause
Have not seen improvement with hormone therapy alone
Are looking for a targeted way to boost sex drive
Want a clinically guided approach to sexual health

Your provider will review your symptoms, medical history, and goals to determine if PT-141 is appropriate for you.